BD Expanding Safety Needle Technology Platform With Saf-T-Med Buy
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson plans to initiate marketing feedback studies of Saf-T-Med's Easy Safe retracting needle syringe within 12 months, the company says.
You may also be interested in...
Becton Dickinson Signs Sharps Agreement But Predicts Disappointing Quarter
Becton Dickinson's safety engineered "sharps" program with Kaiser Permanente, announced June 16, signals the initial success of a strategy that is expected to carry the company out of its recent warnings of slower growth.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.